Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
Home Editorial Board Current Issue Special Issue Archives Indexing Submit Article
Instruction to Authors Manuscript Charges Copyright Form Model Manuscript Process Flow (Time Frame) FAQ
Reviewer Guidelines Selection of Reviewers Join our Team of Reviewers Apply as Reviewer Reviewer Login
Editorial Review Policy Embargo Policy Ethical Expectations Consent For Identifying Information Informed Consent Manuscript Withdrawal Policy Peer Review Process Plagiarism Policy Ethical Violations Appeal Policy Against Editorial Decision Advertising Policies Authorship Policy
Access Policies Authorship Publication Policy Publication Ethics Complaints Policy Confidential Information Conflicts of Interest Policy Consent for Copyrighted Material Copyright Policy Corrections and Retractions Digital Preservation Policy Research On Human And Animal Studies Open Access Policy
Publication Ethics Contact
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2023 - IJCMAS--ICV 2023: 95.56 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Join as a Reviewer

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2020)
[Effective from January 1, 2020]
For more details click here
ICV 2023: 95.56
Index Copernicus ICI Journals Master List 2023 - IJCMAS--ICV 2023: 95.56
For more details click here
Announcement

See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 14, Issue:12, December, 2025
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38
Metrics and citations

Int.J.Curr.Microbiol.App.Sci.2025.14(12): 240-245
DOI: https://doi.org/10.20546/ijcmas.2025.1412.023


Burden and Screening Yield of Hepatitis B, Hepatitis C, and Dengue in Western Rajasthan, India
Jayant Ramawat1*, Deepak Kanjani1 and Amrin Khan2
1Department of Microbiology, Dr. SN Medical College, Jodhpur, India 2Department of IHBT, Mahatma Gandhi Medical College, Jaipur, India
*Corresponding author
Abstract:

Hepatitis B virus (HBV), Hepatitis C virus (HCV), and Dengue fever continue to pose major public health challenges in India. Rapid Diagnostic Tests (RDTs) are widely used due to their simplicity, rapid turnaround time, and suitability in resource-limited settings. Understanding positivity trends in large-scale screenings can inform public health strategies. A retrospective observational analysis was conducted on 8475 samples tested at Infectious Disease Institute (IDI), KNCH Hospital, Jodhpur (Rajasthan) from 1 January 2024 to 30 November 2024. A total of 4196 samples were tested for HBsAg, 4134 for HCV, and 145 for Dengue using standardized rapid card testing protocols. Positivity rates were calculated for each infection and interpreted in the context of existing epidemiological evidence. Among 4196 HBsAg samples, 428 were positive (10.2%). Out of 4134 HCV samples, 123 tested positive (3.0%). Dengue RDT showed 23 positive cases (15.9%) out of 145 samples. HBsAg positivity indicated a persistent burden of Hepatitis B infection. Dengue positivity reflected seasonal transmission dynamics, while HCV positivity remained comparatively lower. Rapid card tests demonstrate effective applicability for large-scale screening of HBV, HCV, and Dengue infections. The notable HBsAg positivity underscores the need for sustained vaccination and screening programs, while the high Dengue positivity during seasonal surges highlights the importance of timely diagnosis in outbreak settings. Integration of RDTs into routine diagnostic and surveillance strategies can significantly aid early detection and public health response.


Keywords: Hepatitis B, Hepatitis C, Dengue, Rapid Diagnostic Test, Positivity Trend, Screening

References:
  1. Cruz HM, Scalioni Lde P, de Paula VS, da Silva EF, do Ó KM, Milagres FA, et al., Evaluating HBsAg rapid test performance for different biological samples from low and high infection rate settings & populations. BMC Infect Dis. 2015; 15: 548. https://doi.org/10.1186/s12879-015-1249-5.
  2. World Health Organization. Hepatitis B Key Facts. WHO; 2024.
  3. World Health Organization. Hepatitis C Key Facts. WHO; 2024.
  4. World Health Organization. Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. WHO; 2009.
  5. National Centre for Disease Control (NCDC). Dengue Situation in India – Epidemiological Updates. Directorate General of Health Services, Govt. of India; 2024.
  6. Ministry of Health and Family Welfare. National Viral Hepatitis Control Program (NVHCP) – Operational Guidelines. Government of India; 2018.
  7. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B Virus Infection: Epidemiology and Vaccination. Epidemiol Rev. 2006; 28: 112-25. https://doi.org/10.1093/epirev/mxj009.
  8. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. The global epidemiology and genotype distribution of hepatitis C virus infection. J Hepatol. 2014; 61(1 Suppl): S45–57. https://doi.org/10.1016/j.jhep.2014.07.027.
  9. Choudhury N, Phadke S, Koshy A, Agrawal G. Transfusion Transmitted Infections in India: A Systematic Review. Asian J Transfus Sci. 2010; 4(2): 116-21.
  10. Vijay Kumar TS, Harshvardhan R, Srinivas A, Venu Gopal. Seroprevalence of Hepatitis B Surface Antigen and Anti-HCV Antibodies in a Tertiary Care Hospital in India. Indian J Pathol Microbiol. 2016; 59(2): 195-9.
  11. Ganju SA, Kanga A, Singh D, Verma AK. Seroprevalence of Hepatitis B and C Viruses in Healthy Blood Donors in Shimla, India. Indian J Med Microbiol. 2013; 31(4): 357-9.
  12. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al., Global Distribution and Burden of Dengue. Nature. 2013; 496(7446):504-7. https://doi.org/10.1038/nature12060.
  13. World Health Organization. Global Strategy for Dengue Prevention and Control 2012–2020. WHO; 2012.
  14. Peeling RW, Artsob H, Pelegrino JL, Buchy P, Cardosa MJ, Devi S, et al., Evaluation of Diagnostic Tests: Dengue. Nat Rev Microbiol. 2010; 8(12 Suppl): S30-8.
  15. Blacksell SD. Commercial Dengue Rapid Diagnostic Tests for Point-of-Care Application: Recent Evaluations and Future Needs. J Biomed Biotechnol. 2012; 2012: 151967. https://doi.org/10.1155/2012/151967.
Download this article as Download

How to cite this article:

Jayant Ramawat, Deepak Kanjani and Amrin Khan. 2025. Burden and Screening Yield of Hepatitis B, Hepatitis C, and Dengue in Western Rajasthan, IndiaInt.J.Curr.Microbiol.App.Sci. 14(12): 240-245. doi: https://doi.org/10.20546/ijcmas.2025.1412.023
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations
Home | Terms of Use | Copyright Form 2012-2020 Copy rights reserved IJCMAS. Powered by ThinkNEXT Technologies